RESUMEN
AIM: To study the magnitude and correlation of humoral and cellular immune responses to hepatitis surface antigen(HBsAg), preS1+S2 antigen, and core antigen(HBcAg) in the blood donors. METHODS: Enzyme linked immunosorbent assay (ELISA) was employed to scan the humoral immune responses to HBsAg, preS1+S2 antigen, and HBcAg. Enzyme linked immunospot assay (ELISPOT) was used to check the antigen specific IFN-γ secreting cells stimulated by HBsAg, preS1+S2 antigen or HBcAg in peripheral blood mononuclear cell from blood donors. RESULTS: The prevalence of humoral immune response to preS1+S2 antigen was as high as 85.7% (48/56), compared with the lower response to HBcAg (30.4%, 17/56). In the cellular immune response, there was no difference between preS1+S2 antigen and HBcAg, both of which were stronger than the response stimulated by HBsAg. PreS1+S2 antigen or HBsAg specific humoral immune and cellular immune responses were highly correlated, which could not be observed in the HBcAg specific humoral immune and cellular immune responses(P>0.05). CONCLUSION: Either humoral or cellular immune responses to HBsAg, preS1+S2 antigen and HBcAg could be detected in the blood donors. PreS1+S2 antigen immune responses, however, were most powerful, which may suggest that PreS1+S2 antigen may be a candidate for the further HBV vaccine.
Asunto(s)
Donantes de Sangre , Virus de la Hepatitis B/inmunología , Inmunidad Celular/inmunología , Inmunidad Humoral/inmunología , Adulto , Ensayo de Inmunoadsorción Enzimática , Femenino , Anticuerpos contra la Hepatitis B/sangre , Anticuerpos contra la Hepatitis B/inmunología , Antígenos del Núcleo de la Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/inmunología , Humanos , Interferón gamma/inmunología , Interferón gamma/metabolismo , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Masculino , Precursores de Proteínas/inmunología , Adulto JovenRESUMEN
AIM: To expand HBV special interferon-γ secreting human T lymphocytes in vitro and sustain the ability to recognize special T cell epitodes of HBcAg. METHODS: After stimulated by peptide 22 hours, feeded with autologous peripheral blood mononuclear cells ( PBMCs) deproliferated by mitomycin C and low concentration of IL-2 to expand in vitro for other 4 weeks. Then cells were collected and tested by flow cells assay every week. The ability of these cells to recognize special epitodes was tested by enzyme linked immunospot assay in which autologous lymphoblastoid cell lines (LCLs) produced from PBMC was transfected by epstein-barr virus pulsed with peptides and used as target cell. RESULTS: HBV special interferon-secreting human T lymphocytes were selected and expanded more than 1000 times in vitro. The ability of the T cells to recognize special epitodes is as same as unexpanded cells and the proportion of CD4 and CD8 positive cells likely remained native state. CONCLUSION: HBV special interferon-γ secreting T lymphocytes are effectively expanded in vitro and keep the ability to recognize stringently special T cell epotides.